FindTrial
Sign In

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-002938-37-ES
Enrollment
Unknown
Registered
2012-08-07
Start date
2012-09-25
Completion date
Unknown
Last updated
2012-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Vistabel® Product Name: Vistabel Product Code: Vistabel Pharmaceutical Form: Powder and solution for solution for injection INN or Proposed INN: Onabotulinumtoxina A (Vistabel®) Current Sp

Sponsors

DR. JAVIER ANIDO RUBIO
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: NA Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 60 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
Main Objective: NA;Secondary Objective: NA;Primary end point(s): NA;Timepoint(s) of evaluation of this end point: NA—

Secondary

MeasureTime frame
Secondary end point(s): NA;Timepoint(s) of evaluation of this end point: NA—

Countries

Spain

Contacts

Public ContactDr. Javier Anido

Clinica Gaztambide

dr.anido@hotmail.com91 544 24 93

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026